Top-Rated StocksTop-RatedNASDAQ:LFST LifeStance Health Group (LFST) Stock Price, News & Analysis $7.39 0.00 (0.00%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$7.39 0.00 (0.00%) As of 05/22/2026 07:44 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About LifeStance Health Group Stock (NASDAQ:LFST) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get LFST alerts:Sign Up Key Stats Today's Range$7.24▼$7.4650-Day Range$6.24▼$8.8552-Week Range$3.74▼$8.89Volume3.23 million shsAverage Volume7.98 million shsMarket Capitalization$2.87 billionP/E Ratio123.17Dividend YieldN/APrice Target$9.86Consensus RatingBuy Company Overview LifeStance Health Group (NASDAQ:LFST) is a leading provider of outpatient mental health services in the United States. Headquartered in New York City, the company operates a growing network of clinics that deliver integrated, patient-centered psychological and psychiatric care. LifeStance’s mission is to expand access to high-quality mental health treatment by combining evidence-based therapy modalities with personalized treatment plans. The company’s service offerings include individual, family, and group psychotherapy, psychiatric medication management, psychological assessment, and telehealth services. Clinicians at LifeStance employ a range of therapeutic approaches—such as cognitive behavioral therapy (CBT), dialectical behavior therapy (DBT), and trauma-informed care—to address conditions including anxiety, depression, attention-deficit/hyperactivity disorder (ADHD), and other mental health challenges. Telehealth options further enhance access for patients facing geographic or scheduling limitations. LifeStance partners with health plans, employer-sponsored programs, and governmental payers to integrate its services into broader healthcare ecosystems. These collaborations facilitate in-network access through major insurance carriers and support employer wellness initiatives aimed at improving workforce mental health. Since its inception, the company has expanded both organically and through strategic acquisitions to establish a broad national footprint and meet the increasing demand for outpatient behavioral health services. AI Generated. May Contain Errors. Read More LifeStance Health Group Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks74th Percentile Overall ScoreLFST MarketRank™: LifeStance Health Group scored higher than 74% of companies evaluated by MarketBeat, and ranked 174th out of 869 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.5 / 5Analyst RatingBuy Consensus RatingLifeStance Health Group has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 strong buy ratings, 6 buy ratings, 2 hold ratings, and no sell ratings.Upside PotentialLifeStance Health Group has a consensus price target of $9.86, representing about 33.4% upside from its current price of $7.39.Amount of Analyst CoverageLifeStance Health Group has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about LifeStance Health Group's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth75.00% Earnings GrowthEarnings for LifeStance Health Group are expected to grow by 75.00% in the coming year, from $0.12 to $0.21 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of LifeStance Health Group is 123.17, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 39.03.Price to Earnings Ratio vs. SectorThe P/E ratio of LifeStance Health Group is 123.17, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 21.01.Price to Book Value per Share RatioLifeStance Health Group has a P/B Ratio of 1.94. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about LifeStance Health Group's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.91% of the float of LifeStance Health Group has been sold short.Short Interest Ratio / Days to CoverLifeStance Health Group has a short interest ratio ("days to cover") of 1.17, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in LifeStance Health Group has recently increased by 5.09%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldLifeStance Health Group does not currently pay a dividend.Dividend GrowthLifeStance Health Group does not have a long track record of dividend growth. News and Social Media0.0 / 5News SentimentN/A News Coverage This WeekMarketBeat has tracked 1 news article for LifeStance Health Group this week, compared to 3 articles on an average week.Search InterestOnly 1 people have searched for LFST on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added LifeStance Health Group to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Company Ownership1.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, LifeStance Health Group insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $85,295,948.00 in company stock.Percentage Held by Insiders3.20% of the stock of LifeStance Health Group is held by insiders.Percentage Held by Institutions85.50% of the stock of LifeStance Health Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about LifeStance Health Group's insider trading history. Receive LFST Stock News and Ratings via Email Sign-up to receive the latest news and ratings for LifeStance Health Group and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. LFST Stock News HeadlinesInsider Selling: LifeStance Health Group (NASDAQ:LFST) Director Sells $1,951,763.24 in StockMay 17, 2026 | americanbankingnews.comLifeStance Health Group (NASDAQ:LFST) Director Sells $4,611,772.68 in StockMay 17, 2026 | americanbankingnews.comThe REAL Reason Trump is Invading IranFor a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.May 25 at 1:00 AM | Banyan Hill Publishing (Ad)Darren Black Sells 5,899,661 Shares of LifeStance Health Group (NASDAQ:LFST) StockMay 16, 2026 | americanbankingnews.comEric Shuey Sells 243,362 Shares of LifeStance Health Group (NASDAQ:LFST) StockMay 15, 2026 | insidertrades.comLifeStance Health Group (NASDAQ:LFST) Given New $9.00 Price Target at JPMorgan Chase & Co.May 15, 2026 | americanbankingnews.comBarclays Sticks to Its Buy Rating for Lifestance Health Group (LFST)May 14, 2026 | theglobeandmail.comLifeStance Health Group (NASDAQ:LFST) Director Robert Bessler Sells 7,752 SharesApril 28, 2026 | insidertrades.comSee More Headlines LFST Stock Analysis - Frequently Asked Questions How have LFST shares performed this year? LifeStance Health Group's stock was trading at $7.04 on January 1st, 2026. Since then, LFST stock has increased by 5.0% and is now trading at $7.39. How were LifeStance Health Group's earnings last quarter? LifeStance Health Group, Inc. (NASDAQ:LFST) released its quarterly earnings results on Wednesday, May, 6th. The company reported $0.04 earnings per share for the quarter, topping analysts' consensus estimates of $0.01 by $0.03. The company's quarterly revenue was up 21.2% on a year-over-year basis. Read the conference call transcript. Is LifeStance Health Group doing a stock buyback? LifeStance Health Group's Board of Directors initiated a stock buyback plan on Wednesday, February 25th 2026, which permits the company to buy back $100,000,000 in outstanding shares, according to EventVestor. This means that the company could reacquire up to 3.6% of its shares through open market purchases. Shares repurchase plans are usually an indication that the company's management believes its shares are undervalued. When did LifeStance Health Group IPO? LifeStance Health Group (LFST) raised $640 million in an initial public offering (IPO) on Wednesday, June 9th 2021. The company issued 40,000,000 shares at a price of $15.00-$17.00 per share. Morgan Stanley, Goldman Sachs, J.P. Morgan, Jefferies, TPG Capital BD LLC, UBS Investment Bank and William Blair acted as the underwriters for the IPO and Capital One Securities, AmeriVet, Drexel Hamilton, R. Seelaus & Co. and Siebert Williams Shank were co-managers. Who are LifeStance Health Group's major shareholders? LifeStance Health Group's top institutional shareholders include Dimensional Fund Advisors LP (2.67%), Jennison Associates LLC (2.64%), Silversmith Partners I GP LLC (1.59%) and Principal Financial Group Inc. (0.79%). Insiders that own company stock include Tpg Gp A, Llc, Summit Partners Growth Equity, Summit Partners L P, Darren M Black, Silversmith Partners I Gp, Llc, Warren Gouk, Kevin Michael Mullins, Robert Bessler, Eric Shuey, Ryan Pardo, Danish J Qureshi, David Bourdon, Ann Varanakis, Anisha Patel-Dunn, Lisa K Miller, Paula Cipollone and Ujjwal Ramtekkar. View institutional ownership trends. How do I buy shares of LifeStance Health Group? Shares of LFST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of LifeStance Health Group own? Based on aggregate information from My MarketBeat watchlists, some other companies that LifeStance Health Group investors own include Waste Connections (WCN), American Water Works (AWK), The RMR Group (RMR), AUO (AUOTY), DiamondRock Hospitality (DRH), iShares Micro-Cap ETF (IWC) and Triple Flag Precious Metals (TFPM). Company Calendar Last Earnings5/06/2026Today5/25/202646th Annual William Blair Growth Stock Conference6/04/2026Next Earnings (Estimated)8/06/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (9m+) 1-Year History May 25 Aug 25 Nov 25 Feb 26 May 26 LFST's financial health is in the Green zone, according to TradeSmith. LFST has been in this zone for over 9 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED - OUTP/HM CRE Sub-IndustryHealthcare Current SymbolNASDAQ:LFST CIK1845257 Webwww.lifestance.com Phone602-767-2100FaxN/AEmployees10,961Year Founded2017Price Target and Rating Average Price Target for LifeStance Health Group$9.86 High Price Target$12.00 Low Price Target$8.00 Potential Upside/Downside+33.4%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage10 Analysts Profitability EPS (Trailing Twelve Months)$0.06 Trailing P/E Ratio123.17 Forward P/E Ratio61.58 P/E GrowthN/ANet Income$9.66 million Net Margins1.55% Pretax Margin2.25% Return on Equity1.56% Return on Assets1.07% Debt Debt-to-Equity Ratio0.18 Current Ratio1.48 Quick Ratio1.48 Sales & Book Value Annual Sales$1.42 billion Price / Sales2.01 Cash Flow$0.17 per share Price / Cash Flow43.93 Book Value$3.81 per share Price / Book1.94Miscellaneous Outstanding Shares387,830,000Free Float375,423,000Market Cap$2.87 billion OptionableOptionable Beta1.20 Social Links 7 Stocks to Buy And Hold ForeverClick the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report This page (NASDAQ:LFST) was last updated on 5/25/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LifeStance Health Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LifeStance Health Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
